70 10.0 REFERENCES ..................................................................................................................................... 71 Aduro Biotech , Inc. Protocol ADU -CL-02-v8 CRS -207 with Pemetrexed and Cisplatin Version 8, 08 March 2018 Page xv LIST OF FIGURES AND TABLES Page Figure 1. Cyclophosphamide Followed by CRS -207 Improves Vaccine Potency. ..........................................